Therapy with recombinant human antithrombin, heparin and tissue plasminogen activator improves survival and reduces ventilation days in a long-term ovine model of cutaneous burn and smoke inhalation injury
2011

Triple Therapy Improves Survival in Burn and Smoke Inhalation Injury

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): Asmussen S, Yamamoto Y, Traber DL, Ito H, Cox R, Hawkins H, Traber LD, Herndon D, Enkhbaatar P

Primary Institution: University of Texas Medical Branch, Galveston, TX, USA

Hypothesis

This triple therapy decreases the requirement of ventilation, reduces ventilation days and improves survival.

Conclusion

The triple therapy may be a novel and efficient therapeutic alternative to improve the outcome of burn patients with smoke inhalation injury.

Supporting Evidence

  • All treated sheep survived and were weaned from the ventilator.
  • Four out of five treatment sheep could be decannulated from the tracheostomy tube at 72 hours.
  • Only three out of five control sheep survived 96 hours.

Takeaway

The study tested a new treatment for sheep with severe burns and smoke inhalation, and it helped them breathe better and survive.

Methodology

Ten female sheep were randomly allocated to control or treatment groups, with the treatment group receiving a combination of rhAT, heparin, and tPA.

Participant Demographics

Ten female sheep, average weight 34.4 kg.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/cc9600

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication